TY - JOUR T1 - Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures JO - Neurology PY - 1997/01/01 AU - Beydoun A AU - Fischer J AU - Labar DR AU - Harden C AU - Cantrell D AU - Uthman BM AU - Sackellares JC AU - Abou-Khalil B AU - Ramsay RE AU - Hayes A AU - Greiner M et al ED - DO - DOI: 10.1212/wnl.49.3.746 PB - Ovid Technologies (Wolters Kluwer Health) VL - 49 IS - 3 SP - 746 EP - 752 Y2 - 2025/05/26 ER -